Oral administration of cysteine peptides attenuates UV-B-induced skin erythema and pigmentation in humans

Sci Rep. 2024 Sep 27;14(1):22163. doi: 10.1038/s41598-024-73447-z.

Abstract

The oral administration of antioxidants may suppress UV-B-induced skin damage. HITHION YH-15, the extract of Torula yeast (Cyberlindnera jadinii), is rich in cysteine-containing peptides such as reduced and oxidized glutathione (GSH and GSSG), γ-glutamylcysteine (γ-Glu-Cys), and cysteinylglycine (Cys-Gly). These four constituents are termed cysteine peptides. In this study, we investigated the protective effects of cysteine peptides against UV-B in a randomized, placebo-controlled, double-blind, parallel-group study. A total of 90 healthy males and females aged 30-59 years were enrolled and randomized into two groups of 45 individuals each (cysteine peptides (48 mg/day) and placebo). Changes in UV-B-induced erythema and pigmentation were compared between groups after 5 weeks of test food intake. The minimal erythema dose (MED) significantly increased (*p = 0.019) in the cysteine peptides group compared to that in the placebo group, indicating suppression of UV-B-induced erythema. ΔL* value significantly increased (***p < 0.0001) in the cysteine peptides group compared to that in the placebo, indicating pigmentation suppression. We demonstrated that oral administration of cysteine peptides suppresses UV-B-induced erythema and pigmentation through multiple mechanisms. Thus, cysteine peptides may find use as nutricosmetics for maintaining skin health and well-being.UMIN Clinical Trials Registry ID: UMIN 000050157.

Keywords: Cysteine peptides; Cysteinylglycine; Erythema; Glutathione; MED; Pigmentation; UV; Ultraviolet; γ-glutamylcysteine.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Administration, Oral
  • Adult
  • Antioxidants / administration & dosage
  • Antioxidants / pharmacology
  • Cysteine* / administration & dosage
  • Cysteine* / pharmacology
  • Double-Blind Method
  • Erythema* / drug therapy
  • Erythema* / etiology
  • Erythema* / prevention & control
  • Female
  • Humans
  • Male
  • Middle Aged
  • Peptides / administration & dosage
  • Peptides / pharmacology
  • Skin / drug effects
  • Skin / pathology
  • Skin / radiation effects
  • Skin Pigmentation* / drug effects
  • Skin Pigmentation* / radiation effects
  • Ultraviolet Rays* / adverse effects

Substances

  • Cysteine
  • Peptides
  • Antioxidants